Vicore Pharma Holding AB
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 1,599.0% | 8,826.0% | 5,694.1% | 26,978.0% | 17,042.4% | 5,370.6% | 8,712.9% | |
| 332.4% | 1,583.6% | 806.2% | 5,265.6% | 3,573.4% | 1,491.9% | 1,820.6% | |
| 1,943.8% | 10,362.9% | 6,467.2% | 32,011.0% | 20,672.3% | 6,882.8% | 10,518.2% | |
| -1,843.8% | -10,262.9% | -6,367.2% | -31,911.0% | -20,572.3% | -6,782.8% | -10,418.2% | |
| 0.0% | 2,960.2% | 830.5% | 2,039.9% | 106.8% | 0.0% | 475.7% | |
| -1,647.6% | -12,503.9% | -6,607.3% | -32,721.5% | -18,028.2% | -6,446.9% | -10,113.8% | |
| -1,647.6% | -12,503.9% | -6,607.3% | -32,721.5% | -18,042.5% | -6,454.8% | -10,119.0% | |
| – | – | -5,776.8% | -30,681.6% | -17,921.4% | -6,446.9% | -9,638.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.